Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Intensive lowering of low-density lipoprotein cholesterol levels for primary prevention of coronary artery disease.

Karalis DG.

Mayo Clin Proc. 2009 Apr;84(4):345-52. doi: 10.1016/S0025-6196(11)60544-2. Review.

PMID:
19339653
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Managing dyslipidemia in the high-risk patient.

Stein EA.

Am J Cardiol. 2002 Mar 7;89(5A):50C-57C. Review.

PMID:
11900720
[PubMed - indexed for MEDLINE]
3.

Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Kones R.

Drug Des Devel Ther. 2011;5:325-80. doi: 10.2147/DDDT.S14934. Epub 2011 Jun 13. Review.

PMID:
21792295
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.

PMID:
15161326
[PubMed - indexed for MEDLINE]
5.

Update on the National Cholesterol Education Program Adult Treatment Panel III guidelines: getting to goal.

McKenney JM.

Pharmacotherapy. 2003 Sep;23(9 Pt 2):26S-33S. Review.

PMID:
14524636
[PubMed - indexed for MEDLINE]
6.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. Review.

PMID:
15358046
[PubMed - indexed for MEDLINE]
Free Article
7.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e149-61. Review.

PMID:
15297292
[PubMed - indexed for MEDLINE]
Free Article
8.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association.

Circulation. 2004 Jul 13;110(2):227-39. Review. Erratum in: Circulation. 2004 Aug 10;110(6):763.

PMID:
15249516
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis.

Jones PH, Nair R, Thakker KM.

J Am Heart Assoc. 2012 Dec;1(6):e001800. doi: 10.1161/JAHA.112.001800. Epub 2012 Dec 19.

PMID:
23316314
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Attainment of normal lipid levels among patients on lipid-modifying therapy in Hong Kong.

Ambegaonkar B, Chirovsky D, Tse HF, Lau YK, Tomlinson B, Li SK, Yue CS, Wong TH, Choi MC, Tunggal P, Sazonov V.

Adv Ther. 2012 May;29(5):427-41. doi: 10.1007/s12325-012-0017-9. Epub 2012 May 3.

PMID:
22562782
[PubMed - indexed for MEDLINE]
12.

Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.

Bersot TP, P├ępin GM, Mahley RW.

Am Heart J. 2003 Dec;146(6):1052-9.

PMID:
14660998
[PubMed - indexed for MEDLINE]
13.

New features of the National Cholesterol Education Program Adult Treatment Panel III lipid-lowering guidelines.

Brewer HB Jr.

Clin Cardiol. 2003 Apr;26(4 Suppl 3):III19-24.

PMID:
12708635
[PubMed - indexed for MEDLINE]
14.

Low-density lipoprotein apheresis: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2007;7(5):1-101. Epub 2006 Nov 1.

PMID:
23074505
[PubMed]
Free PMC Article
15.

Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.

Mann D, Reynolds K, Smith D, Muntner P.

Ann Pharmacother. 2008 Sep;42(9):1208-15. doi: 10.1345/aph.1L181. Epub 2008 Jul 22.

PMID:
18648016
[PubMed - indexed for MEDLINE]
16.

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr.

JAMA. 1998 May 27;279(20):1615-22.

PMID:
9613910
[PubMed - indexed for MEDLINE]
17.

Aggressive lipid management for cardiovascular prevention: evidence from clinical trials.

Friday KE.

Exp Biol Med (Maywood). 2003 Jul;228(7):769-78. Review.

PMID:
12876295
[PubMed - indexed for MEDLINE]
18.

[Statins in primary prevention of coronary heart disease].

Paulweber B.

Wien Med Wochenschr. 1999;149(5-6):129-38. Review. German.

PMID:
10408004
[PubMed - indexed for MEDLINE]
19.

Therapeutic implications of recent ATP III guidelines and the important role of combination therapy in total dyslipidemia management.

Boden WE.

Curr Opin Cardiol. 2003 Jul;18(4):278-85. Review.

PMID:
12858126
[PubMed - indexed for MEDLINE]
20.

Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy.

Hunninghake DB.

Am J Med. 1998 Feb 23;104(2A):9S-13S.

PMID:
9550501
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk